Sandra P. A. Câmara

Dr. Sandra P. A. Câmara

Universidade dos Açores

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2021 in Foods
Verified
Journal Article
Open access
PDF file
MDMaria de Lurdes Nunes Enes Dapkevicius
Maria de Lurdes Nunes Enes Dapkevicius
BSBruna Sgardioli
Bruna Sgardioli
SCSandra P. A. Câmara
Sandra P. A. Câmara
Patrícia PoetaPatrícia Poeta
Patrícia Poeta
FMFrancisco Malcata
Francisco Malcata
As a genus that has evolved for resistance against adverse environmental factors and that readily exchanges genetic elements, enterococci are well adapted to the cheese environment and may reach high numbers in artisanal cheeses. Their metabolites impact cheese flavor, texture, and rheological properties, thus contributing to the development of its typical sensorial properties. Due to their antimicrobial activity, enterococci modulate the cheese microbiota, stimulate autolysis of other lactic acid bacteria (LAB), control pathogens and deterioration microorganisms, and may offer beneficial effects to the health of their hosts. They could in principle be employed as adjunct/protective/probiotic cultures; however, due to their propensity to acquire genetic determinants of virulence and antibiotic resistance, together with the opportunistic character of some of its members, this genus does not possess Qualified Presumption of Safety (QPS) status. It is, however, noteworthy that some putative virulence factors described in foodborne enterococci may simply reflect adaptation to the food environment and to the human host as commensal. Further research is needed to help distinguish friend from foe among enterococci, eventually enabling exploitation of the beneficial aspects of specific cheese-associated strains. This review aims at discussing both beneficial and deleterious roles played by enterococci in artisanal cheeses, while highlighting the need for further research on such a remarkably hardy genus.

4 September 2021 in Foods
Verified
Journal Article
Open access
PDF file
Carla MirandaCarla Miranda
Carla Miranda
DCDiogo Contente
Diogo Contente
Gilberto IgrejasGilberto Igrejas
Gilberto Igrejas
SCSandra P. A. Câmara
Sandra P. A. Câmara
MDMaria de Lurdes Nunes Enes Dapkevicius
Maria de Lurdes Nunes Enes Dapkevicius
Patrícia PoetaPatrícia Poeta
Patrícia Poeta
Animal products, in particular dairy and fermented products, are major natural sources of lactic acid bacteria (LAB). These are known for their antimicrobial properties, as well as for their roles in organoleptic changes, antioxidant activity, nutrient digestibility, the release of peptides and polysaccharides, amino acid decarboxylation, and biogenic amine production and degradation. Due to their antimicrobial properties, LAB are used in humans and in animals, with beneficial effects, as probiotics or in the treatment of a variety of diseases. In livestock production, LAB contribute to animal performance, health, and productivity. In the food industry, LAB are applied as bioprotective and biopreservation agents, contributing to improve food safety and quality. However, some studies have described resistance to relevant antibiotics in LAB, with the concomitant risks associated with the transfer of antibiotic resistance genes to foodborne pathogens and their potential dissemination throughout the food chain and the environment. Here, we summarize the application of LAB in livestock and animal products, as well as the health impact of LAB in animal food products. In general, the beneficial effects of LAB on the human food chain seem to outweigh the potential risks associated with their consumption as part of animal and human diets. However, further studies and continuous monitorization efforts are needed to ensure their safe application in animal products and in the control of pathogenic microorganisms, preventing the possible risks associated with antibiotic resistance and, thus, protecting public health.

24 April 2025 in Foods
Verified
Journal Article
Open access
PDF file
SCSandra P. A. Câmara
Sandra P. A. Câmara
CDCristina Maduro Dias
Cristina Maduro Dias
HNHelder Patrício Barcelos Nunes
Helder Patrício Barcelos Nunes
RMRaphaël Martin
Raphaël Martin
FPFrancisca Pamplona Pimentel
Francisca Pamplona Pimentel
MDMaria de Lurdes Nunes Enes Dapkevicius
Maria de Lurdes Nunes Enes Dapkevicius
Artisanal cheeses face unique challenges due to changes in the present approaches to food safety, health, and environmental sustainability. This work aims at tackling such challenges in Pico cheese, by addressing outdated PDO criteria, the need to tackle coagulase-positive staphylococci (CoPS) and to promote circular economy by upgrading cheese whey. Model raw- and pasteurized milk cheeses were prepared with autochthonous lactic acid bacteria (LAB) as inoculants and analyzed for their composition, proteolysis, and microbiological parameters. CoPS were isolated and the risks they pose in terms of One Health evaluated by assessing phenotypic virulence factors and antibiotic resistance patterns. To assess the potential of autochthonous LAB for controlling CoPS, a challenge test was performed. Probiotic requeijão was prepared using autochthonous LAB as inoculants for upgrading whey. This work confirmed the need to update Pico cheese specifications regarding proteolysis indexes. Biofilm production was present in all Pico cheese CoPS, but resistance was only found against penicillin and cefoxitin. Adding salt or extending maturation time up to 60 days did not afford the desired level of CoPS control. Lactococcus lactis L1C21M1, however, was able to keep CoPS populations at 3 log cfu g−1 in the challenge test. Requeijão was a suitable substrate for probiotic autochthonous Lactococcus lactis L3A21M1 and L3B1M7.

25 March 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
SCSandra P. A. Câmara
Sandra P. A. Câmara
CDCristina Maduro Dias
Cristina Maduro Dias
HNHelder Patrício Barcelos Nunes
Helder Patrício Barcelos Nunes
RMRaphaël Martin
Raphaël Martin
FPFrancisca Pamplona Pimentel
Francisca Pamplona Pimentel
MDMaria de Lurdes Nunes Enes Dapkevicius
Maria de Lurdes Nunes Enes Dapkevicius
Artisanal cheeses face unique challenges, due to changes in the present approaches to food safety, health, and environmental sustainability. This work aims at tackling such challenges in Pico cheese, by addressing outdated PDO criteria, the need to tackle coagulase-positive staphylococci (CoPS) and to promote circular economy by upgrading cheese whey. Model raw- and pasteurized milk cheeses were prepared with autochthonous lactic acid bacteria (LAB) as inoculants and analyzed for their composition, proteolysis, and microbiological parameters. CoPS were isolated and the risks they pose in terms of One Health evaluated by assessing phenotypic virulence factors and antibiotic resistance patterns. To assess the potential of autochthonous LAB for controlling CoPS, a challenge test was performed. Probiotic requeijão was prepared using autochthonous LAB as inoculants for upgrading whey. This work confirmed the need to update Pico cheese specifications regarding proteolysis indexes. Biofilm production was present in all Pico cheese CoPS, but resistance was only found against penicillin and cefoxitin. Adding salt or extending maturation time up to 60 days did not afford the desired level of CoPS control. Lactococcus lactis L1C21M1, however, was able to keep CoPS populations at 3 log cfu g-1 in the challenge test. Requeijão was a suitable substrate for probiotic autochthonous Lactococcus lactis L3A21M1 and L3B1M7.